PER1 and neoplasm: Tumor growth was significantly suppressed with the TRAS + PER combination compared with TRAS and PER alone (tumor growth inhibition rates on day 22 were 19% with TRAS, 18% with PER, and 58% with TRAS + PER in the OE19bTDR xenograft model) (Fig. 6b).